Application 220238
- Type
- ANDA
- Sponsor
- QILU PHARMACEUTICAL CO., LTD.
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | ABEMACICLIB | ABEMACICLIB | TABLET | 150MG | No | No |
| 003 | ABEMACICLIB | ABEMACICLIB | TABLET | 100MG | No | No |
| 004 | ABEMACICLIB | ABEMACICLIB | TABLET | 50MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Verzenio | ABEMACICLIB | Eli Lilly and Company | be4bc0de-0fdc-4d46-8d25-be43c79e6a06 | 2026-07-13 | Warnings, Adverse reactions | ABEMACICLIB |